sglt2 inhibitors and glp-1 receptor agonists together Diabetic Agents, From Metformin to GLP1 Agonists: JACC Focus Seminar Illustration of potential synergistic effects
Description
Regular physical activity, especially strength training, is also critical to helping slow the loss of muscle during weight-loss therapy
What was your strategy
Hypothalamic inflammation in obesity and metabolic disease
Long-Term Safety: Although GLP-1 medications have demonstrated efficacy and safety in clinical trials, their long-term safety profile is still being evaluated
They also slow progression of diabetic kidney disease and are associated with beneficial effects like lower blood pressure and improved lipid profiles ( [8] ) ( [7] )
Alcohol use A patient with a history of excess alcohol use must be advised to stop consuming alcohol before starting GLP-1 receptor agonist therapy
